The main goals of therapy for patients with heart failure with preserved ejection fraction are to address the signs and symptoms of heart failure, improve quality of life, and reduce the risk of ...

The new approach is designed to create a connection between the left and right atrial chambers of the heart in a single ...

Faun1083 has demonstrated positive in-vivo efficacy in multiple preclinical animal models, including rat sugen hypoxia and ZSF1 studies, which are common models to study key features of heart failure ...

Alleviant Medical announced that it received FDA investigational device exemption and breakthrough device designation for its ...

Background Heart failure (HF) guidelines recommend routine testing for iron deficiency (ID) and, for those with ID, ...

KDEV) today announces that its portfolio company AnaCardio has secured SEK 205 million in a series A extension financing round and reports positive results from the first part of a Phase 1b/2a study ...

Benefiting from technological and conceptual groundwork and positive early data, gene therapies are advancing in the clinic ...

Kerenida is currently approved to slow the progression chronic kidney disease associated with type 2 diabetes.

Berlin: Bayer has announced the submission of marketing authorization applications to the U.S. Food and Drug Administration ...

New findings on semaglutide and tirzepatide published in 2024 revealed that the medications may have benefits beyond lowering ...